Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/57433
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLadawan Khowawisetsuten_US
dc.contributor.authorPatsharaporn T. Sarasombathen_US
dc.contributor.authorSuwich Thammapaloen_US
dc.contributor.authorSumart Loymeken_US
dc.contributor.authorTherayot Korbarsaen_US
dc.contributor.authorHathai Nochoteen_US
dc.contributor.authorAchinya Phuakroden_US
dc.contributor.authorWej Choochoteen_US
dc.contributor.authorSirichit Wongkamchaien_US
dc.date.accessioned2018-09-05T03:41:15Z-
dc.date.available2018-09-05T03:41:15Z-
dc.date.issued2017-10-15en_US
dc.identifier.issn18732550en_US
dc.identifier.issn03044017en_US
dc.identifier.other2-s2.0-85027850290en_US
dc.identifier.other10.1016/j.vetpar.2017.08.009en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85027850290&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/57433-
dc.description.abstract© 2017 Elsevier B.V. Lymphatic filariasis (LF) is one of the neglected tropical diseases which causes permanent and long term disability worldwide. LF is caused by filarial nematode parasites, i.e. Wuchereria bancrofti, Brugia malayi, and B. timori. All available antifilarial drugs currently being used have shown a limited adulticidal activity. Discoveries of endosymbiont rickettsia-like bacterium, Wolbachia in filarial nematodes provided a novel approach for antibiotic use in eradication of filarial diseases. The earlier studies revealed the macrofilaricidal efficacy of doxycycline against filarial nematodes. Chemotherapeutic efficiency of doxycycline has been studied against many filarial parasites, but there are still no therapeutic trials of the drug regimens for B. malayi treatment in naturally infected cats. Thus, this study would be the first attempt to study the efficiency of doxycycline (DOXY) alone or in combination with ivermectin (IVM) for treatment of B. malayi in naturally infected cats. A total of 26 B. malayi-infected cats in the endemic areas were recruited and divided into 3 groups, receiving different treatment regimens; a single dose of ivermectin only (IVM), doxycycline only (DOXY) and a combination of ivermectin and doxycycline (DOXY-IVM). The efficacy of each therapatic regimen was evaluated by detecting the presence of microfilaria using parasitological and molecular techniques monthly up to 2 years after starting the treatment. The IVM treated group had a significant rapid reduction of microfilariae in the first month; however, recurrence of microfilaraemia was observed in some cats. By contrast, the DOXY and DOXY-IVM groups showed a better result with a gradual decrease in microfilariae with no recurrence. These 2 groups were not only virtually deprived of infection but also sustained the sterility of infection through the course of study. These results revealed the advantages of using in B. malayi treatment in cats. Doxycycline showed to have both microfilaricidal and adulticidal effects on lymphatic filariae which maintained the long-term response to control of B. malayi infection in cats.en_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectVeterinaryen_US
dc.titleTherapeutic trial of doxycyclin plus ivermectin for the treatment of Brugia malayi naturally infected catsen_US
dc.typeJournalen_US
article.title.sourcetitleVeterinary Parasitologyen_US
article.volume245en_US
article.stream.affiliationsMahidol Universityen_US
article.stream.affiliationsThailand Ministry of Public Healthen_US
article.stream.affiliationsFaculty of Medicine, Chiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.